United Therapeutics Corporation Amortization of Debt Issuance Costs and Discounts
United Therapeutics Corporation (UTHR) reported Amortization of Debt Issuance Costs and Discounts of $100.00 thousand for the 6-month period ending 2016-06-30, per its 10-Q filed 2016-07-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2016-07-28
- United Therapeutics Corporation amortization of debt issuance costs and discounts for the quarter ending 2016-06-30 was $0.00, a 100.00% decline year-over-year.
- United Therapeutics Corporation amortization of debt issuance costs and discounts for the quarter ending 2016-03-31 was $100.00K, a 95.00% decline year-over-year.
- United Therapeutics Corporation amortization of debt issuance costs and discounts for the quarter ending 2015-12-31 was $433.00K, a 82.60% decline year-over-year.
- United Therapeutics Corporation amortization of debt issuance costs and discounts for the quarter ending 2015-09-30 was $408.00K, a 88.13% decline year-over-year.
- United Therapeutics Corporation amortization of debt issuance costs and discounts for fiscal 2015 was $5.94M, a 52.30% decline from fiscal 2014.
- United Therapeutics Corporation amortization of debt issuance costs and discounts for fiscal 2014 was $12.46M, a 1.15% decline from fiscal 2013.
- United Therapeutics Corporation amortization of debt issuance costs and discounts for fiscal 2013 was $12.60M, a 13.89% increase from fiscal 2012.
- United Therapeutics Corporation amortization of debt issuance costs and discounts for fiscal 2012 was $11.06M, a 42.85% decline from fiscal 2011.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 3 month as first filed | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 6 month as first filed | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|---|---|
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $100.00K 10-Q · filed 2016-07-28 | $533.00K derived: sum of 3 quarters · filed 2016-07-28 | $941.00K derived: sum of 4 quarters · filed 2016-07-28 | ||
| 2016-03-31 | $100.00K 10-Q · filed 2016-04-28 | $533.00K derived: sum of 2 quarters · filed 2016-04-28 | $941.00K derived: sum of 3 quarters · filed 2016-04-28 | $4.04M derived: sum of 4 quarters · filed 2016-07-28 | ||
| 2015-12-31 | $433.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $841.00K derived: sum of 2 quarters · filed 2016-02-25 | $3.94M derived: sum of 3 quarters · filed 2016-07-28 | $5.94M 10-K · filed 2016-02-25 | ||
| 2015-09-30 | $408.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-27 | $3.51M derived: sum of 2 quarters · filed 2016-07-28 | $5.51M 10-Q · filed 2015-10-27 | $8.00M derived: sum of 4 quarters · filed 2016-07-28 | ||
| 2015-06-30 | $3.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $5.10M 10-Q · filed 2016-07-28 | $5.05M 10-Q · filed 2015-07-28 | $7.59M derived: sum of 3 quarters · filed 2016-07-28 | $11.02M derived: sum of 4 quarters · filed 2016-07-28 | |
| 2015-03-31 | $2.00M 10-Q · filed 2016-04-28 | $2.00M 10-Q · filed 2015-04-28 | $4.49M derived: sum of 2 quarters · filed 2016-04-28 | $7.92M derived: sum of 3 quarters · filed 2016-04-28 | $11.19M derived: sum of 4 quarters · filed 2016-04-28 | |
| 2014-12-31 | $2.49M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $5.92M derived: sum of 2 quarters · filed 2016-02-25 | $9.19M derived: sum of 3 quarters · filed 2016-02-25 | $12.46M 10-K · filed 2016-02-25 | ||
| 2014-09-30 | $3.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-27 | $6.70M derived: sum of 2 quarters · filed 2015-10-27 | $9.97M 10-Q · filed 2015-10-27 | $13.16M derived: sum of 4 quarters · filed 2016-02-25 | ||
| 2014-06-30 | $3.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-28 | $6.53M 10-Q · filed 2015-07-28 | $9.72M derived: sum of 3 quarters · filed 2016-02-25 | $12.89M derived: sum of 4 quarters · filed 2016-02-25 | ||
| 2014-03-31 | $3.27M 10-Q · filed 2015-04-28 | $6.45M derived: sum of 2 quarters · filed 2016-02-25 | $9.63M derived: sum of 3 quarters · filed 2016-02-25 | $12.78M derived: sum of 4 quarters · filed 2016-02-25 | ||
| 2013-12-31 | $3.19M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $6.36M derived: sum of 2 quarters · filed 2016-02-25 | $9.52M derived: sum of 3 quarters · filed 2016-02-25 | $12.60M 10-K · filed 2016-02-25 | ||
| 2013-09-30 | $3.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28 | $6.33M derived: sum of 2 quarters · filed 2014-10-28 | $9.41M 10-Q · filed 2014-10-28 | $11.57M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2013-06-30 | $3.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-29 | $6.24M 10-Q · filed 2014-07-29 | $8.40M derived: sum of 3 quarters · filed 2015-02-24 | $11.40M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2013-03-31 | $3.08M 10-Q · filed 2014-04-29 | $5.25M derived: sum of 2 quarters · filed 2015-02-24 | $8.24M derived: sum of 3 quarters · filed 2015-02-24 | $11.22M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2012-12-31 | $2.16M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $5.16M derived: sum of 2 quarters · filed 2015-02-24 | $8.14M derived: sum of 3 quarters · filed 2015-02-24 | $11.06M 10-K · filed 2015-02-24 | ||
| 2012-09-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-29 | $5.98M derived: sum of 2 quarters · filed 2013-10-29 | $8.90M 10-Q · filed 2013-10-29 | $14.61M derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2012-06-30 | $2.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | $5.91M 10-Q · filed 2013-07-25 | $11.62M derived: sum of 3 quarters · filed 2014-02-25 | $16.24M derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2012-03-31 | $2.92M 10-Q · filed 2013-04-25 | $8.64M derived: sum of 2 quarters · filed 2014-02-25 | $13.26M derived: sum of 3 quarters · filed 2014-02-25 | $17.81M derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2011-12-31 | $5.71M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $10.34M derived: sum of 2 quarters · filed 2014-02-25 | $14.89M derived: sum of 3 quarters · filed 2014-02-25 | $19.36M 10-K · filed 2014-02-25 | ||
| 2011-09-30 | $4.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $9.18M derived: sum of 2 quarters · filed 2012-11-01 | $13.65M 10-Q · filed 2012-11-01 | $17.97M derived: sum of 4 quarters · filed 2013-02-26 | ||
| 2011-06-30 | $4.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-26 | $9.02M 10-Q · filed 2012-07-26 | $13.34M derived: sum of 3 quarters · filed 2013-02-26 | $17.59M derived: sum of 4 quarters · filed 2013-02-26 | ||
| 2011-03-31 | $4.47M 10-Q · filed 2012-04-26 | $8.79M derived: sum of 2 quarters · filed 2013-02-26 | $13.04M derived: sum of 3 quarters · filed 2013-02-26 | $17.21M derived: sum of 4 quarters · filed 2013-02-26 | ||
| 2010-12-31 | $4.32M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $8.57M derived: sum of 2 quarters · filed 2013-02-26 | $12.74M derived: sum of 3 quarters · filed 2013-02-26 | $16.84M 10-K · filed 2013-02-26 | ||
| 2010-09-30 | $4.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | $8.42M derived: sum of 2 quarters · filed 2011-10-27 | $12.52M 10-Q · filed 2011-10-27 | $16.55M derived: sum of 4 quarters · filed 2012-02-28 | ||
| 2010-06-30 | $4.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | $8.27M 10-Q · filed 2011-07-28 | $12.30M derived: sum of 3 quarters · filed 2012-02-28 | $16.27M derived: sum of 4 quarters · filed 2012-02-28 | ||
| 2010-03-31 | $4.10M 10-Q · filed 2011-04-28 | $8.13M derived: sum of 2 quarters · filed 2012-02-28 | $12.09M derived: sum of 3 quarters · filed 2012-02-28 | |||
| 2009-12-31 | $4.03M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $7.99M derived: sum of 2 quarters · filed 2012-02-28 | $15.71M 10-K · filed 2012-02-28 | |||
| 2009-09-30 | $3.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-28 | $11.69M 10-Q · filed 2010-10-28 | ||||
| 2009-06-30 | $7.72M 10-Q · filed 2010-07-28 | |||||
| 2008-12-31 | $14.67M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |